Skip to content
2000
Volume 4, Issue 13
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Unpredictable efficacy and toxicity are major hurdles in the administration of many medications. By identifying inherited DNA polymorphisms that influence drug disposition and effects, pharmacogenomics is an exciting tool for the individualization of drug therapies. Single nucleotide polymorphisms (SNP) in genes encoding drug metabolizing enzymes, drug transporters, and DNA repair genes have recently been shown to influence drug toxicity and efficacy. This review will discuss clinically relevant examples of genetic polymorphisms that influence the outcome of drug therapy, and possibilities for future applications of pharmacogenomics.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026043387638
2004-09-01
2025-06-15
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026043387638
Loading

  • Article Type:
    Review Article
Keyword(s): drug therapy; pharmacogenetics; pharmacogenomics; snp
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test